| 产品编号 | CFN60053 | |
| CAS编号 | 873054-44-5 | |
| 分子式 = 分子量 | C24H28N2O3 = 392.49 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 依伐卡托 | CFN60053 | 873054-44-5 | 1mg | QQ客服:2056216494 |
| 依伐卡托 | CFN60053 | 873054-44-5 | 5mg | QQ客服:2056216494 |
| 依伐卡托 | CFN60053 | 873054-44-5 | 10mg | QQ客服:2056216494 |
| 依伐卡托 | CFN60053 | 873054-44-5 | 20mg | QQ客服:2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Ivacaftor (VX-770) is a selective potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM in fisher rat thyroid cells, respectively. | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.5478 mL | 12.7392 mL | 25.4784 mL | 50.9567 mL | 63.6959 mL |
| 5 mM | 0.5096 mL | 2.5478 mL | 5.0957 mL | 10.1913 mL | 12.7392 mL |
| 10 mM | 0.2548 mL | 1.2739 mL | 2.5478 mL | 5.0957 mL | 6.3696 mL |
| 50 mM | 0.051 mL | 0.2548 mL | 0.5096 mL | 1.0191 mL | 1.2739 mL |
| 100 mM | 0.0255 mL | 0.1274 mL | 0.2548 mL | 0.5096 mL | 0.637 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 泻根醇酸; Bryonolic acid | CFN98260 | 24480-45-3 | C30H48O3 = 456.7 | 5mg | QQ客服:1413575084 |
| Phalaenopsine T; Phalaenopsine T | CFN00302 | 23412-97-7 | C20H27NO5 = 361.44 | 5mg | QQ客服:3257982914 |
| Rupesin E; Rupesin E | CFN96703 | 924901-58-6 | C15H22O5 = 282.33 | 5mg | QQ客服:2159513211 |
| (2S,3S)-4-羟基-2,3-双[(4-羟基-3,5-二甲氧基苯基)甲基]丁基beta-D-吡喃木糖苷; Ssioriside | CFN99379 | 126882-53-9 | C27H38O12 = 554.6 | 5mg | QQ客服:2056216494 |